It’s more than just a game. Sports can be a powerful force in a girl's life, helping to build confidence, connection and healthy habits. But too often, barriers like cost and access keep girls on the sidelines. Through The Court Is Hers™, we’re supporting efforts to provide free local basketball leagues and clinics, helping more girls find their place on the court. Learn more: https://e.lilly/48lHN9n #WeAreLilly
Eli Lilly and Company
Pharmaceutical Manufacturing
Indianapolis, Indiana 2,412,881 followers
About us
We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges. General Information and Guidelines: When you engage with us on LinkedIn, you're agreeing to these Community Guidelines: https://e.lilly/guidelines. If you have questions about a Lilly medicine, contact The Lilly Answers Center at 1-800-Lilly-Rx (1-800-545-5979) Monday through Friday, excluding company holidays.
- Website
-
http://www.lilly.com/
External link for Eli Lilly and Company
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- Indianapolis, Indiana
- Type
- Public Company
- Specialties
- Pharmaceutical Development, Pharmaceuticals, Biotech, and Biopharmaceuticals
Locations
-
Primary
Get directions
Lilly Corporate Center
Indianapolis, Indiana 46285, US
Employees at Eli Lilly and Company
Updates
-
Breakthroughs in science happen when innovators come together. That’s why Gateway Labs is expanding to Philadelphia—to connect the city’s brightest biotech minds with the resources, expertise and lab facilities needed to tackle the toughest diseases. By supporting collaboration across the scientific community, we’re helping accelerate discoveries that could change lives for people who need them most. Learn more about our newest Gateway Labs site: https://e.lilly/4o6ox4G #WeAreLilly
-
For the Team USA athletes competing in the Olympic and Paralympic Winter Games Milano Cortina 2026, every medal or record broken is an incredible step in achieving a goal. Through our Milestones into Meaning™ program, it’s also a step towards better health for all. Learn how each #TeamUSA achievement also means a $5,000 donation from Lilly to U.S. nonprofit organizations for charitable programs that expand general healthcare access: https://e.lilly/4oVhAEi #WeAreLilly
-
-
The FDA has announced that it has given us an expedited review of the once-a-day weight loss pill we’re investigating, potentially giving people living with obesity a new treatment option early next year. https://e.lilly/4orN7h8
-
-
With an exciting portfolio and pipeline of new medicines, our opportunity to transform human health has never been greater. We’re adding two new exceptional leaders to drive our expansion plans in neuroscience and immunology. https://e.lilly/497sGkS #WeAreLilly
-
-
Everyone deserves a chance at better health. For years, we’ve been pioneering solutions to help people afford our medicines — and driving change to close gaps in the U.S. health care system that prevent affordable access. Today we announced an agreement with the U.S. government to make it easier for millions more people to get our obesity treatments at a lower cost — including coverage through Medicare. Read more: https://e.lilly/47tdUDZ
-
The GLP-1 hormone gets a lot of press, but other hormones also play an important role in managing food intake – including one called amylin. Our researchers are studying a potential medicine that selectively activates the amylin receptor, with the hope of providing another option to people living with obesity. Today at the #ObesityWeek conference, we presented positive mid-stage data on this potential next-generation medicine to treat obesity. Read more: https://e.lilly/3Ls450f
-
We're investing $3 billion in a new manufacturing facility in Katwijk, Netherlands. It’s our latest milestone in strengthening a resilient, global supply chain for oral medicines. This expansion complements our recent growth in the U.S. and underscores our commitment to meeting rising demand across key therapeutic areas. By manufacturing closer to the communities we serve, we’re accelerating access to innovative treatments, bringing them to more patients, faster. Learn more about our M&Q commitment: https://e.lilly/437NnJQ #WeAreLilly
-
A newly operational wind farm in Texas now produces renewable electricity for approximately 95% of our North American operations—a meaningful step toward our goal of sourcing 100% renewable electricity globally by 2030. We’re making steady progress on our sustainability commitments. Learn more: https://e.lilly/3JpZhHE #WeAreLilly
-